(Q45734610)

15 December 2017

Inhibition of IFN-gamma signaling by an Epstein-Barr virus immediate-early protein (English)

1 reference

15 December 2017

0 references

Morrison TE

1

1 reference

15 December 2017

Mauser A

2

1 reference

15 December 2017

Wong A

3

1 reference

15 December 2017

Ting JP

4

1 reference

15 December 2017

Kenney SC

5

1 reference

15 December 2017

language of work or name

English

0 references

publication date

1 November 2001

1 reference

15 December 2017

1 reference

15 December 2017

15

1 reference

15 December 2017

787-799

1 reference

15 December 2017

5

1 reference

Modulation of major histocompatibility class II protein expression by varicella-zoster virus

15 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900226-6

7 January 2021

The Epstein-Barr virus BZLF1 protein interacts physically and functionally with the histone acetylase CREB-binding protein

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900226-6

7 January 2021

Epstein-barr virus immediate-early protein BZLF1 is SUMO-1 modified and disrupts promyelocytic leukemia bodies

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900226-6

7 January 2021

Epstein-Barr virus immediate-early proteins BZLF1 and BRLF1 activate the ATF2 transcription factor by increasing the levels of phosphorylated p38 and c-Jun N-terminal kinases

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900226-6

7 January 2021

The IFN gamma receptor: a paradigm for cytokine receptor signaling

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900226-6

7 January 2021

Initial and innate responses to viral infections--pattern setting in immunity or disease

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900226-6

7 January 2021

Cellular responses to interferon-gamma

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900226-6

7 January 2021

Identification of cellular target genes of the Epstein-Barr virus transactivator Zta: activation of transforming growth factor beta igh3 (TGF-beta igh3) and TGF-beta 1

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900226-6

7 January 2021

The Epstein-Barr virus latency BamHI-Q promoter is positively regulated by STATs and Zta interference with JAK/STAT activation leads to loss of BamHI-Q promoter activity

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900226-6

7 January 2021

The biology of Epstein-Barr virus: lessons learned from the virus and the host

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900226-6

7 January 2021

Epstein-Barr virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900226-6

7 January 2021

Immune interferon activates multiple class II major histocompatibility complex genes and the associated invariant chain gene in human endothelial cells and dermal fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900226-6

7 January 2021

Activation of expression of latent Epstein-Barr herpesvirus after gene transfer with a small cloned subfragment of heterogeneous viral DNA

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900226-6

7 January 2021

Replication of Epstein-Barr virus oriLyt: lack of a dedicated virally encoded origin-binding protein and dependence on Zta in cotransfection assays.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900226-6

7 January 2021

Characterization of the Epstein-Barr virus BZLF1 protein transactivation domain

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900226-6

7 January 2021

KSHV ORF K9 (vIRF) is an oncogene which inhibits the interferon signaling pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900226-6

7 January 2021

Transcriptional interference between the EBV transcription factors EB1 and R: both DNA-binding and activation domains of EB1 are required

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900226-6

7 January 2021

Interferons inhibit onset of murine cytomegalovirus immediate-early gene transcription.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900226-6

7 January 2021

The bZIP transactivator of Epstein-Barr virus, BZLF1, functionally and physically interacts with the p65 subunit of NF-kappa B

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900226-6

7 January 2021

A new Epstein-Barr virus transactivator, R, induces expression of a cytoplasmic early antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900226-6

7 January 2021

Class II transactivator: mastering the art of major histocompatibility complex expression

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900226-6

7 January 2021

Murine cytomegalovirus inhibits interferon gamma-induced antigen presentation to CD4 T cells by macrophages via regulation of expression of major histocompatibility complex class II-associated genes

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900226-6

7 January 2021

The Epstein-Barr virus BMLF1 promoter contains an enhancer element that is responsive to the BZLF1 and BRLF1 transactivators

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900226-6

7 January 2021

Overlapping elements in the guanylate-binding protein gene promoter mediate transcriptional induction by alpha and gamma interferons

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900226-6

7 January 2021

Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900226-6

7 January 2021

Epstein-Barr virus infection and replication in a human epithelial cell system

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900226-6

7 January 2021

Responsiveness of the Epstein-Barr virus NotI repeat promoter to the Z transactivator is mediated in a cell-type-specific manner by two independent signal regions

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900226-6

7 January 2021

Serum Levels of Lymphokines and Soluble Cellular Receptors in Primary Epstein-Barr Virus Infection and in Patients with Chronic Fatigue Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900226-6

7 January 2021

Human cytomegalovirus inhibits major histocompatibility complex class II expression by disruption of the Jak/Stat pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900226-6

7 January 2021

The growing family of interferon regulatory factors.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900226-6

7 January 2021

Requirement for natural killer cell-produced interferon gamma in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900226-6

7 January 2021

Structure and function of the Epstein-Barr virus BZLF1 protein

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900226-6

7 January 2021

Lymphocytes recognize human vascular endothelial and dermal fibroblast Ia antigens induced by recombinant immune interferon

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900226-6

7 January 2021

Interferon gamma regulates acute and latent murine cytomegalovirus infection and chronic disease of the great vessels

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900226-6

7 January 2021

Direct BRLF1 binding is required for cooperative BZLF1/BRLF1 activation of the Epstein-Barr virus early promoter, BMRF1.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900226-6

7 January 2021

A replication function associated with the activation domain of the Epstein-Barr virus Zta transactivator

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900226-6

7 January 2021

A transcription factor with homology to the AP-1 family links RNA transcription and DNA replication in the lytic cycle of Epstein-Barr virus.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900226-6

7 January 2021

Activation of transcription by IFN-gamma: tyrosine phosphorylation of a 91-kD DNA binding protein

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900226-6

7 January 2021

A single phosphotyrosine residue of Stat91 required for gene activation by interferon-gamma

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900226-6

7 January 2021

Interferon-induced nuclear signalling by Jak protein tyrosine kinases

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900226-6

7 January 2021

Epstein–Barr Virus Replication in Oropharyngeal Epithelial Cells

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900226-6

7 January 2021

The extracellular domain of the Epstein-Barr virus BZLF2 protein binds the HLA-DR beta chain and inhibits antigen presentation

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900226-6

7 January 2021

How cells respond to interferons

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900226-6

7 January 2021

Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome)

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900226-6

7 January 2021

The Epstein-Barr virus BARF1 gene encodes a novel, soluble colony-stimulating factor-1 receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900226-6

7 January 2021

Viral subversion of the immune system

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900226-6

7 January 2021

Epstein-Barr viral latency is disrupted by the immediate-early BRLF1 protein through a cell-specific mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900226-6

7 January 2021

Functional and physical interaction between p53 and BZLF1: implications for Epstein-Barr virus latency

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2801%2900226-6

7 January 2021

10.1016/S1074-7613(01)00226-6

Identifiers

DOI

1 reference

15 December 2017

1 reference